OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.63
-0.01 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
2.70
2.50%
After-hours: Aug 15, 2025, 04:08 PM EDT
OKYO Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -7.09K | -9.57K | -12.12K | -5.54M | -5.54M | -8.41M | -8.41M | -5.43M | -5.43M | -5.35M | -5.35M | -3.97M | -3.97M | -1.61M | -1.61M | -1.54M |
Depreciation & Amortization | 1.28K | 2.69 | 3.16 | 1.67K | 1.66K | 1.66K | 1.65K | 16.53K | 16.53K | 26.66K | 26.67K | 13.32K | 13.31K | 9.01K | 9.01K | 6.03K |
Stock-Based Compensation | 899.87 | 945.69 | 1K | 1.32K | 1.31K | 1.32K | 1.31K | 1.31K | 1.35K | 1.2K | 1.06K | 762.17 | 459.46 | 262.83 | 63.86 | 63.52 |
Other Working Capital | 36.31 | 29.31 | 23.53 | 1.05M | 1.05M | 1.89M | 1.89M | -245.44K | -245.49K | 101.66K | 101.94K | 865.62K | 865.63K | -424.51K | -424.51K | 311.87K |
Other Non-Cash Items | 1.25K | 2.99K | 3.48K | 685.49K | 685.37K | 1.77M | 1.76M | 1.86M | 1.86M | 1.24M | 1.24M | 1.01M | 1.01M | 202.92K | 202.22K | 153.88K |
Deferred Income Tax | n/a | -0.00 | -0.00 | 131.24K | 131.24K | 131.24K | 131.24K | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 30.30 | 56.73 | 86.18 | 1.19M | 1.19M | 1.34M | 1.34M | -1.01M | -1.01M | 40.7K | 40.98K | 1.08M | 1.08M | 59.24K | 59.35K | 166.93K |
Operating Cash Flow | -3.64K | -5.57K | -7.55K | -3.53M | -3.53M | -5.86M | -5.86M | -5.35M | -5.35M | -4.16M | -4.16M | -1.68M | -1.68M | -869.97K | -869.66K | -1.37M |
Capital Expenditures | n/a | -1.46 | -2.95 | -2.95K | -2.95K | -4.65K | -4.65K | -1.71K | -1.71K | -4.89K | -4.89K | -6.79K | -6.79K | -1.9K | -1.9K | -0.75 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.52K | -11.52K | -11.52K | -11.52K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | -3.84 | -8.11 | -8.11 | -8.11 | -56.44 | -104.34 | -104.34 |
Investing Cash Flow | n/a | -1.46 | -2.95 | -2.95K | -2.95K | -4.65K | -4.65K | -1.71K | -1.71K | -16.4K | -16.41K | -18.31K | -18.31K | -1.96K | -2K | -105.09 |
Debt Repayment | 550K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.48 | -8.48 | -8.48 | -8.48 | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 554.08K | 6.02K | 9.51K | -2.42M | -2.42M | -2.41M | -2.41M | -1.43M | -1.43M | 6.53M | 6.53M | 7.91M | 7.91M | -74.67K | -74.48K | -2.97K |
Financial Cash Flow | 554.08K | 6.02K | 9.51K | 1.81M | 1.81M | 1.77M | 1.77M | 1.41M | 1.41M | 2.01M | 2.01M | 8.17M | 8.17M | 8.09M | 8.09M | 996K |
Net Cash Flow | -4.05K | -4.05K | -2.52K | -2M | -2M | -4.48M | -4.49M | -4.18M | -4.18M | -2.26M | -2.26M | 6.65M | 6.65M | 7.38M | 7.38M | -370.58K |
Free Cash Flow | -3.64K | -5.57K | -7.55K | -3.53M | -3.53M | -5.86M | -5.86M | -5.36M | -5.35M | -4.16M | -4.16M | -1.69M | -1.69M | -871.87K | -871.56K | -1.37M |